Low expression of human β-defensin 1 in duodenum of celiac patients is partially restored by a gluten-free diet

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 4, 2010, Pages 489-492

  Intrieri, Mariano ^a,b,c   Rinaldi, Assunta ^b   Scudiero, Olga ^a,b   Autiero, Giovanni ^a   Castaldo, Giuseppe ^a,b   Nardone, Gerardo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^c UNIVERSITY OF MOLISE   (Italy)

Author keywords

defensins; Celiac disease

Indexed keywords

BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; BETA DEFENSIN 4; MESSENGER RNA; THYROGLOBULIN ANTIBODY;

ADULT; ARTICLE; CELIAC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DUODENUM; ENDOSCOPY; GENE EXPRESSION; GLUTEN FREE DIET; HUMAN; INTESTINE BIOPSY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RELAPSE; REMISSION;

ADULT; AUTOANTIBODIES; BETA-DEFENSINS; BIOPSY; CELIAC DISEASE; DIET, GLUTEN-FREE; DUODENUM; HUMANS; RECURRENCE; RNA, MESSENGER;

BACTERIA (MICROORGANISMS);

EID: 77949856336     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.098     Document Type: Article

References (15)

1. Sollid MS, Gray GM. A role for bacteria in celiac disease? Am J Gastroenterol 2004;99:905-906
2. Tursi A. High prevalence of small intestinal bacteria overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal. Am J Gastroenterol 2003;98:838-843
3. Gianfrani C, Auricchio S, Troncone R. Adaptive and innate immune responses in celiac disease. Immunol Lett 2005;99:141-145
4. Tang YQ, Yuan J, Osapay G, Osapay K, Tran D, Miller CJ, et al. A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins. Science 1999; 286:498-502.
5. Bulet P, Stocklin R, Menin L. Anti-microbial peptides: from invertebrates to vertebrates. Immunol Rev 2004;198:169-184
6. Wehkamp J, Fellermann K, Herrlinger KR, Bevins CL, Stage EF. Mechanisms of disease: defensins in gastrointestinal disease. Nature Clin Pract 2005;2:406-415
7. Pazgier M, Hoover DM, Yang D, Lu W, Lubkowski J. Human b-defensins. Cell Mol Life Sci 2006;63:1294-1313
8. Mendez A, Finlay B. Defensins in the immunology of bacterial infections. Curr Opin Immunol 2007;19:385-391
9. Schneider JJ, Unholzer A, Schaller M, Schäfer-Korting M, Korting HC. Human defensins. J Mol Med 2005;83:587-595
10. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-DDCT method. Methods 2001;25:402-408
11. Garcia JR, Krause A, Schulz S, Rodriguez-Jiménez FJ, Kluver E, Adermann K, et al. Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J 2001;15:1819-1821
12. Taha AS, Faccenda E, Angerson WJ, Balsitis M, Kelly RW. Natural antibiotic expression in celiac disease - correlation with villous atrophy and response to a gluten-free diet. Digest Diseas Sci 2005;50:791-795
13. Harder J, Bartels J, Christophers J, Schroder JM. A peptide antibiotic from human skin. Nature 1997;387:861.
14. Forsberg G, Fahlgren A, Horstedt P, Hammarstrom S, Hernell O. Presence of bacteria and innate immunity of intestinal epithelium in childhood celiac disease. Am J Gastroenterol 2004; 99:894-904.
15. Vankeerberghen A, Scudiero O, De Boeck K, Macek M Jr, Pignatti PF, Van Hul N, et al. Distribution of human b-defensin polymorphisms in various control and cystic fibrosis populations. Genomics 2005;85:574-581